文献速递临床生化质量管理与危急值

生物标志物结果对终身医疗保健的务实贡献

Striving for a pragmatic contribution of biomarkers results to lifelong health care.
PubMed 文献 · Clin Chem Lab Med · 2023-02-17

本文探讨临床化学与新生儿筛查中生物标志物如何务实用于医疗决策。有效性受分析性能、疾病患病率、诊断流程整合、成本及假阳性/假阴性社会影响等因素制约,需进行成本效果分析并克服分析缺陷、改进解释标准。新生儿筛查面临方法结果不一致和健康效果有限的问题,需多学科合作以支持政策制定。

要点

  • 生物标志物有效性取决于分析性能、患病率、诊断流程整合及假阳性/假阴性成本。
  • 需开展成本效果分析,克服分析缺陷并改进解释标准以确保可靠性。
  • 新生儿筛查存在方法间结果不一致和健康效果有限的问题,需多学科协作。

核心结论

  • 预防医学的兴起为检验医学改变生物标志物对医疗保健有效性的评估方式提供了关键机会。

研究设计与样本

  • 本文为综述,旨在描述临床化学或新生儿筛查领域的实验室专业人员与计量经济学、生物信息学和生物统计学专家合作,如何务实利用实验室结果改善医疗决策。

主要发现

  • 生物标志物对医疗保健的有效性取决于分析性能、疾病患病率、检测在诊断算法中的整合、相关成本以及假阳性和假阴性的社会/经济影响。
  • 新生儿筛查的主要问题之一是不同方法获得的结果缺乏协调性以及健康效果有限。

临床怎么用

  • 临床实验室应整合不同技术和方法学专长的专业人员,并与其他学科合作,以表征检测对流行病学结局的影响,支持医疗政策制定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The increased role of preventive medicine in healthcare and the rapid technological advancements, have deeply changed the landscape of laboratory medicine. In particular, increased investments in newborn screening tests and policies have been observed. Aim of this paper is to characterize how laboratory professionals engaged in clinical chemistry or newborn screening, in collaboration with experts in econometric, bioinformatics, and biostatistics may address a pragmatic use of laboratory results in the decision-making process oriented toward improvement of health care outcomes. CONTENT: The effectiveness of biomarkers on healthcare depends on several factors such as analytical performance, prevalence of the disease, integration of the test within the diagnostic algorithm, associated costs, and social/economic impact of false positive and false negative results. Cost-effectiveness analysis needs to be performed and reliability achieved, by overcoming analytical pitfalls and by improving interpretative criteria. These are challenging issues common to clinical chemistry and newborn screening tests. Following the experience in clinical chemistry, one of the main issues to be approached in newborn screening tests, is the lack of harmonization of results obtained by different methods and the limited healthcare effectiveness. SUMMARY: The focus on prevention is a crucial opportunity for laboratory medicine to change how to approach the effectiveness of biomarkers on healthcare. The consolidation within clinical laboratories of professionals with different technical and methodological expertise coupled with the need to produce and manage large sets of data, require the cooperation of professionals from other disciplines to characterize the impact of the tests on epidemiological outcomes for health care policy making process.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Ferraro S, Cereda C, Zuccotti G, et al. Striving for a pragmatic contribution of biomarkers results to lifelong health care. Clin Chem Lab Med. 2023. PMID: 36798037. doi:10.1515/cclm-2022-1294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。